Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for February 16, 2012 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



The Spangenberg Shibley & Liber Law Firm Announces the Launch of a New Website Regarding Reported Adverse Side Effects Associated with Use of Pradaxa
Spangenberg Shibley & Liber LLP is investigating internal bleeding and other adverse effects associated with the use of Pradaxa. 
x-small text small text medium text large text



Spangenberg Shibley & Liber LLP
    CLEVELAND, OH, February 16, 2012 /24-7PressRelease/ -- In October of 2010, the FDA approved Pradaxa for the treatment of atrial fibrillation not caused by a heart valve problem. Atrial fibrillation is a condition which occurs when part of the heart does not beat properly causing blood cells to form clots, or coagulate. These blood clots may lead to stroke and in some cases, death.

Pradaxa is included in a class of drugs known as direct thrombin inhibitors. Use of direct thrombin inhibitors is used in blood thinning treatments to prevent coagulation of blood cells. However, shortly after the FDA approved Pradaxa for the treatment of atrial fibrillation, symptoms of Pradaxa internal bleeding were reported.

The most serious side effect associated with Pradaxa is internal bleeding. This occurs as a result of the body excreting the drug through the kidneys, impairing the kidneys ability to function. This leads to an increased amount of the drug traveling throughout the system, causing internal bleeding to occur.

Symptoms of internal bleeding may include:

- Unexpected bleeding or unusually long lasting bleeding
- Severe or uncontrollable bleeding
- Pink or brown urine
- Red or black stools
- Bruises with unknown cause
- Blood clots and coughing up blood
- Blood in vomit or vomit with "coffee grounds" consistency
- Unexpected pain, swelling, joint pain, headaches, dizziness, weakness

The FDA issued a safety communication in December of 2011 stating that the agency is investigating these reports of internal bleeding. Other reported Pradaxa side effects include gastrointestinal bleeding, kidney bleeding, heart attack, brain hemorrhaging, and even death.

Spangenberg Shibley & Liber is investigating potential Pradaxa lawsuits against Boehringer Ingelheim, the makers of Pradaxa, related to injuries suffered from the use of Pradaxa. These cases are complex, and an experienced defective drug attorney will be able to evaluate your case and develop the necessary legal and scientific proof.

Spangenberg Shibley & Liber is a civil litigation trial team with experience representing victims of dangerous drugs and medical devices in state and federal court for decades. The statute of limitations on your claim may already be running, so it is important to contact a Pradaxa attorney promptly to protect your rights in the Pradaxa internal bleeding lawsuit.

1. http://www.fda.gov/Drugs/DrugSafety/ucm282724.htm
2. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm288002.htm#Pradaxa
3. http://online.wsj.com/article/SB10001424052970203436904577151043459695270.html
4. http://www.pradaxapro.com/RELY.jsp

Spangenberg Shibley & Liber LLP is a personal injury law firm headquartered in Ohio. You can contact an attorney at http://www.spanglaw.com/ or by calling 1-877-696-3303 (toll-free).


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Read more Press Releases from Renee Latkovic:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Social Media:
Share or bookmark this story using Facebook, Twitter, Digg, and more.

Bookmark and Share
Press Release Contact Information:
Renee Latkovic
Spangenberg Shibley & Liber LLP

Office Manager
1001 Lakeside Ave E, Suite 1700
Cleveland, Ohio
USA 44114
Voice: 216-586-5508
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.